Mualliflar

  • Магзумова Н.М., Йулдошева Д.К., Ахмедова Г.

##semicolon##

giperandrogeniya, tuxumdon genezli giperandro-genemiya, buyrak usti bezi genezli giperandrogenemiya, polikistoz tuxumdon sindromi, tug‘ma buyrak usti bezi po‘stlog‘ining noklassik giperplaziyasi, reproduktiv disfunksiya.

##submission.citations##

8. Адамян ЛВ, Андреева ЕН, Абсатарова ЮС и др. Син- дром поликистозных яичников: клин. рекомендации. Пробл эндокринол. 2022;68(2):112-127.1( https://doi. org/10.14341/probl12874)

9. Белова ИС, Хащенко ЕП, Уварова ЕВ. Инсулиноре- зистентность и гиперандрогения при СПКЯ. Акуш и гин. 2021; 5:55-63.2 (https://journals.rcsi.science/0300-9092/ article/view/309997)

10. Луценко ЛА. Надпочечниковая гиперандрогения у женщин репродуктивного возраста. Междунар эндо- кринол журн. 2019;15(3):29-36.6 (https://cyberleninka. ru/article/n/nadpochechnikovaya-giperandrogeniya-u- zhenschin-reproduktivnogo-vozrasta)

11. Мельниченко ГА, Трошина ЕА. Врожденная дис- функция коры надпочечников: обновленные рекомен- дации. Consilium Medicum. – 2018;20(4):8-19.7 (https:// cyberleninka.ru/article/n/vrozhdennaya-disfunktsiya-kory- nadpochechnikov-obnovlennye-rekomendatsii)

12. Carmina E, Dewailly D. Ovarian and adrenal hyperandro- genism: differential diagnosis. Best Pract Res Clin Endocrinol Metab. 2018;32(2):141-54.12 (https://doi.org/10.1016/j. beem.2018.02.001)

13. Dokras A et al. Obstetric outcomes in women with PCOS: updated review. Fertil Steril. 2020;113(2):239-48.17 (https:// doi.org/10.1016/j.fertnstert.2019.10.018)

14. Escobar-Morreale HF. Mechanisms of androgen excess in PCOS. Endocrnol. Rev. 2018;39(6):804-36.18 (https://doi. org/10.1210/er.2018-00038)

15. Fornes R. et al. Androgen excess and placental dysfunc- tion. Sci. Rep. 2018;8:8066.19 (https://doi.org/10.1038/ s41598-018-28066-0)

16. Goodarzi MO et al. Molecular genetics of PCOS. Trends Endocrinol Metab. 2023;34(5):315-28.49 (https://doi. org/10.1016/j.tem.2023.02.003)

17. Goodarzi MO, Dumesic DA. Genetics of PCOS. Lancet Diab Endocrinol. 2021;9(8):520-34.21(https://doi.org/10.1016/ S2213-8587(21)00147-3)

18. Hu M et al. Hyperandrogenism and insulin resis- tance in pregnancy. Amer J Physiol Endocrinol Metab. 2019;316:E794-E809.23 (https://doi.org/10.1152/ajpen- do.00428.2018)

19. Joham AE et al. Polycystic ovary syndrome and car- diometabolic risk. Lancet Diab Endocrinol. 2022;10(9):668- 80.24 (https://doi.org/10.1016/S2213-8587(22)00132-5)

20. Kocova M et al. CYP21A2 mutations and female fertility. Eurор J Med Res. 2019;24(21).25 (https://doi.org/10.1186/ s40001-019-0397-8)

21. McCartney C.R., Marshall J.C. Clinical practice update on adolescent hyperandrogenism. J. Clin. Endocrinol. Metab. 2020;105(6):2045-e2056.29 (https://doi.org/10.1210/cli- nem/dgaa045)

22. Moran LJ et al. Obesity and reproductive dysfunction in PCOS. Nat Rev Endocrinol. 2020;16(5):271-83.31 (https://doi. org/10.1038/s41574-020-0340-0)

23. Mossa F et al. Hyperandrogenism during pregnan- cy. Mol Reprod Dev. 2019;86(9):1255-64.32 (https://doi. org/10.1002/mrd.23272)

24. Palomba S et al. Pregnancy complications in women with PCOS. Hum Reprod Update. 2018;24(5):595-614.33 (https:// doi.org/10.1093/humupd/dmy009)

25. Rosenfield RL. Clinical approach to hyperandrogenism. Endocrinol Metab Clin North Amer. 2021;50(1):15-32.35 (https://doi.org/10.1016/j.ecl.2020.11.002)

26. Speiser PW et al. Congenital adrenal hyperplasia clinical practice guideline. J Clin Endocrinol Metab. 2018;103(11):4043- 88.38 (https://doi.org/10.1210/jc.2018-01865)

27. Stener-Victorin E et al. PCOS pathophysiology and meta- bolic dysfunction. Nat Rev Endocrinol. 2022;18(3):155-71.39 (https://doi.org/10.1038/s41574-022-00659-6)

28. Tay CT et al. Cardiovascular risk in PCOS: 2023 guideline update. J Amer Heart Assoc. 2024;13(2):e032145.40 (https:// doi.org/10.1161/JAHA.123.032145)

29. Teede HJ et al. International evidence-based guideline for PCOS. Hum Reprod. 2018;33(9):1602-18.41(https://doi. org/10.1093/humrep/dey256)

30. Teede HJ et al. International PCOS guideline update. Hum Reprod. 2023;38(9):1655-79.42 (https://doi.org/10.1093/ humrep/dead096)

31. Wang Y et al. PCOS and obstetric outcomes. BMC Pregn Childbirth. 2019;19:308.45 (https://doi.org/10.1186/s12884- 019-2321-7)